Can a diabetes drug boost weight loss after surgery?
NCT ID NCT07374445
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looked at whether liraglutide, a drug used for diabetes and weight loss, can help people who are still obese 6 months after metabolic surgery lose more weight. 100 participants received liraglutide injections for 24 weeks along with diet and exercise guidance. The goal was to see if starting liraglutide early after surgery leads to greater weight loss and metabolic benefits.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- liraglutide injection
- What this could lead to
- If it works, this could point toward a way to help people who don't lose enough weight after metabolic surgery achieve further weight loss.
- What could go wrong
- This is a small, completed observational study, not a large randomized trial. Results may not apply to everyone, and liraglutide can cause side effects like nausea or pancreatitis.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BARIATRIC SURGERY are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Nanjing Drum Tower Hospital
Nanjing, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new stomach and gut bypass surgery tackle obesity and diabetes?
- Can a Two-Drug combo tip the scales against obesity?
- Can Weight-Loss surgery change how medications work?
- Coffee grounds probiotic could reshape gut health and fight inflammation
- Can shedding pounds reboot the Heart's exercise engine?
- Can stomach surgery alter how painkillers work?